NCT07526051

Brief Summary

This study examines the effects of autogenic inhibition (PFS) versus reciprocal inhibition in individuals with lower cross syndrome

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started May 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress47%
May 2026Jul 2026

First Submitted

Initial submission to the registry

April 6, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 13, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

May 20, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2026

Last Updated

May 20, 2026

Status Verified

May 1, 2026

Enrollment Period

1 month

First QC Date

April 6, 2026

Last Update Submit

May 18, 2026

Conditions

Lower Cross Syndrome

Outcome Measures

Primary Outcomes (3)

  • Lumbar Range of Motion

    Lumbar spine range of motion will be assessed using inclinometer

    Baseline, 2nd week and 4th week

  • Hip Range of Motion

    Hip range of motion will be assessed using Goniometer

    Baseline, 2nd week and 4th week

  • Functional Disability

    Functional Disability will be measured with Oswestry disability Index, a ten item questionnaire with 6 response options per item.

    Baseline, 2nd week and 4th week

Secondary Outcomes (2)

  • Pain Intensity

    Baseline, 2nd week and 4th week

  • Muscles Strength (Gluteus & Core Muscles)

    Baseline, 2nd week and 4th week

Study Arms (2)

Group A:Autogenic Inhibition(PFS)

EXPERIMENTAL

Group A will receive Autogenic Inhibition (PFS) Technique 10 minutes TENS \& Heating Pad Autogenic Inhibition Technique for 5 sec 5 reps\*5 sec hold\*1 set Strengthening exercises for hip extensors and core muscles

Procedure: Autogenic Inhibition (PFS) Group A

Group B: Reciprocal Inhibition

EXPERIMENTAL

Group B will receive Reciprocal Inhibition Technique 10 minutes TENS \& Heating Pad Reciprocal Inhibition Technique for 5 sec 5 reps\*5 sec hold\*1 set Strengthening exercises for hip extensors and core muscles

Procedure: Reciprocal Inhibition Group B

Interventions

Autogenic Inhibition (PFS) Group APROCEDURE

Patient will receive a four-week physiotherapy program with 3 sessions per week. Each session with heat application followed by supervised stretching and strengthening exercises. Participants in group A will receive Autogenic Inhibition (PFS) 10 minutes TENS \& Heating Pad Autogenic Inhibition for 5 sec 5 reps, 5 sec hold,1 set Frequency: 12 sessions for 4 weeks (3 sessions per week and day of rest between sessions) Total Treatment Time 30 minutes each session Strengthening Exercises for Hip and Core Muscles

Group A:Autogenic Inhibition(PFS)
Reciprocal Inhibition Group BPROCEDURE

Patient will receive a four-week physiotherapy program with 3 sessions per week. Each session with heat application followed by supervised stretching and strengthening exercises. Participants in group B will receive Reciprocal Inhibition 10 minutes TENS \& Heating Pad Inhibition for 5 sec 5 reps,5 sec hold,1 set Frequency: 12 sessions for 4 weeks (3 sessions per week and day of rest between sessions) Total Treatment Time 30 minutes each session Strengthening Exercises for Hip and Core Muscles

Group B: Reciprocal Inhibition

Eligibility Criteria

Age25 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Both Males and Females will be included in our study Age 25-50 years Four positive screening tests (Thomas Test, Abdominal Strength Test, Glutues Maximus Test, Ely's Test) chronic Pain in lower Back Region (\>3 on VAS) lasting for more than 2 months

You may not qualify if:

  • Osteoporosis Congenital Hip Dysplasia History of Fracture History of Inflammatory Arthritis Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Foundation University College of Physical Therapy

Islamabad, Punjab Province, 46000, Pakistan

RECRUITING

Study Officials

  • Zobia Noor, DPT

    Foundation University Islamabad

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Zobia Noor, DPT

CONTACT

0334-8962818zobianoor426@gmail.com

Ruqia Begum, MS-OMPT

CONTACT

03115532544ruqia@fui.edu.pk

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 6, 2026

First Posted

April 13, 2026

Study Start

May 20, 2026

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 15, 2026

Last Updated

May 20, 2026

Record last verified: 2026-05

Locations

PA(1)